• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Ayad, H. (2021). VITAMIN D RECEPTOR PROMOTER METHYLATION STATUS IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSIS. ALEXMED ePosters, 3(2), 56-57. doi: 10.21608/alexpo.2021.79552.1176
Hala Abd-elmawgoud Ayad. "VITAMIN D RECEPTOR PROMOTER METHYLATION STATUS IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSIS". ALEXMED ePosters, 3, 2, 2021, 56-57. doi: 10.21608/alexpo.2021.79552.1176
Ayad, H. (2021). 'VITAMIN D RECEPTOR PROMOTER METHYLATION STATUS IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSIS', ALEXMED ePosters, 3(2), pp. 56-57. doi: 10.21608/alexpo.2021.79552.1176
Ayad, H. VITAMIN D RECEPTOR PROMOTER METHYLATION STATUS IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSIS. ALEXMED ePosters, 2021; 3(2): 56-57. doi: 10.21608/alexpo.2021.79552.1176

VITAMIN D RECEPTOR PROMOTER METHYLATION STATUS IN PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSIS

Article 125, Volume 3, Issue 2, June 2021, Page 56-57  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.79552.1176
View on SCiNiTO View on SCiNiTO
Author
Hala Abd-elmawgoud Ayad email
Clinical pathology , Alexandria university
Abstract
Systemic lupus erythematosus (SLE), is a systemic autoimmune disease, can cause chronic inflammation and damage in several tissues and organs.
Vitamin D, as a steroid hormone, exhibits regulatory effects on growth, proliferation, apoptosis and function of the immune system cells. Vitamin D is associated with pathophysiology of SLE.
The discovery of vitamin D receptor expression by cells of the immune system has spurred more research on the immunomodulatory properties of vitamin D over the past decade.
Vitamin D deficiency is highly prevalent in SLE patients due to the avoidance of sunshine, photoprotection, renal insufficiency and the use of medications such as glucocorticoids, anticonvulsants which alter the metabolism of vitamin D or down regulate the functions of the vitamin D receptor.
The human VDR gene is located inchromosome 12 and contains 14 exons and spans approximately 75 kb. The promoter of the VDR gene is embedded in a GC-rich island with five binding motifs for the transcription factors.The transcriptional activity of VDR could be affected also by epigenetic mechanisms such as DNA methylation which regulate gene expression and chromatin structure.
Keywords
SLE; VIT D; methylation
Supplementary Files
download 0056-1176 Presentation5 (3).pdf
Statistics
Article View: 125
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.